Stage IVA Lung Cancer AJCC v8

specific

Stage IVA includes: (Any T, Any N, M1a); (Any T, Any N, M1b). M1a: Tumor with separate tumor nodule(s) in a contralateral lobe; tumor with pleural or pericardial nodules or malignant pleural or pericardial effusion. Most pleural (pericardial) effusions with lung cancer are a result of the tumor. In a few patients, however, multiple microscopic examinations of pleural (pericardial) fluid are negative for tumor, and the fluid is nonbloody and not an exudate. If these elements and clinical judgment

69

Centers

181

Active Trials

Cancer Funding

Top Centers for Stage IVA Lung Cancer AJCC v8(69)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
172.9
2
High-Volume Research Center
72.2
3
NCI Comprehensive
High-Volume Research Center
71.3
4
NCI Comprehensive
High-Volume Research Center
71.3
5
NCI Comprehensive
Active Research Program
68.7
6
NCI Comprehensive
Active Research Program
68.7
7
NCI Comprehensive
Active Research Program
68.7
8
Active Research Program
68.7
9
Active Research Program
68.7
10
Active Research Program
68.7
11
NCI Comprehensive
Active Research Program
63.8
12
NCI Comprehensive
Active Research Program
63.8
13
NCI Comprehensive
Active Research Program
63.8
14
NCI Comprehensive
Active Research Program
63.8
15
NCI Comprehensive
Active Research Program
63.8
16
Active Research Program
63.8
17
Fox Chase Cancer CenterPhiladelphia, PA
NCI Comprehensive
Active Research Program
63.8
18
Active Research Program
63.8
19
Active Research Program
63.8
20
NCI Comprehensive
Active Research Program
55.9
21
NCI Comprehensive
Active Research Program
55.9
22
NCI Comprehensive
Active Research Program
55.9
23
NCI Comprehensive
Active Research Program
55.9
24
NCI Comprehensive
Active Research Program
55.9
25
NCI Comprehensive
Active Research Program
55.9
26
NCI Clinical
Active Research Program
55.9
27
Active Research Program
55.9
28
NCI Clinical
Active Research Program
55.9
29
NCI Comprehensive
Active Research Program
55.9
30
NCI Clinical
Active Research Program
55.9
31
NCI Comprehensive
Active Research Program
55.9
32
Active Research Program
55.9
33
Active Research Program
55.9
34
Active Research Program
55.9
35
NCI Comprehensive
Active Research Program
45.8
36
NCI Comprehensive
Active Research Program
45.8
37
NCI Comprehensive
Active Research Program
45.8
38
NCI Comprehensive
Active Research Program
45.8
39
NCI Comprehensive
Active Research Program
45.8
40
NCI Comprehensive
Active Research Program
45.8
41
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
45.8
42
NCI Comprehensive
Active Research Program
45.8
43
NCI Comprehensive
Active Research Program
45.8
44
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
45.8
45
Active Research Program
45.8
46
Active Research Program
45.8
47
NCI Basic_laboratory
Active Research Program
45.8
48
Active Research Program
45.8
49
Active Research Program
45.8
50
Active Research Program
45.8
51
NCI Comprehensive
Active Research Program
37.4
52
NCI Comprehensive
Active Research Program
37.4
53
NCI Comprehensive
Active Research Program
37.4
54
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
37.4
55
NCI Comprehensive
Active Research Program
37.4
56
NCI Comprehensive
Active Research Program
37.4
57
NCI Comprehensive
Active Research Program
37.4
5837.4
59
Active Research Program
37.4
60
Active Research Program
37.4
61
NCI Comprehensive
31.2
62
NCI Comprehensive
31.2
6331.2
6431.2
65
NCI Comprehensive
31.2
6631.2
67
NCI Comprehensive
31.2
68
NCI Comprehensive
31.2
6931.2

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →